Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04346589 |
|
Recruitment Status :
Recruiting
First Posted : April 15, 2020
Last Update Posted : June 9, 2020
|
Sponsor:
A.O. Ospedale Papa Giovanni XXIII
Collaborator:
Aferetica - Italy (BO)
Information provided by (Responsible Party):
Piero Luigi Ruggenenti, A.O. Ospedale Papa Giovanni XXIII
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2020 |
| Estimated Study Completion Date : | August 2020 |